This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Low-cost index funds offer broad diversification with minimal fees. This guide explains how to choose funds that track wide market indexes for retirement.
26,677 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Solana is testing the Alpenglow upgrade with validator trials and a potential Q3 mainnet. Analysts weigh timing, risk...
Bitcoin faces first jobs-week as US labor data lands ahead of payrolls, guiding Fed bets and crypto volatility. Inves...
Memory stocks surge as SK Hynix announces a capacity expansion, lifting SanDisk and Western Digital and signaling ren...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
Bitget introduces US stock options and tokenized stocks, a move that fuels debate over ownership on crypto platforms....
A top tech analyst argues memory chips are the AI backbone, with a widening 15-to-1 demand-to-supply gap shaping mark...
Big Tech is hiring high-salary communications leaders who don’t code, aiming to reduce risk and boost clarity amid ra...
A QuidelOrtho Corp director purchases 10,000 shares amid a CFO retirement, sparking investor interest. This article e...
Rivian readies its lower-cost R2 for April deliveries, a pivotal move as analysts weigh its power to expand beyond pr...
Argentina’s wine industry faces its sharpest downturn in over a decade, with record-low consumption and thousands of ...
MSFW has fallen sharply since its July 2025 launch, while weekly payouts crater from a peak of $0.97 to a recent $0.1...